Latest News & Features
Americas
Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated secrets and breached contract | Companies in dispute process and manufacture medical products derived from human placental tissue. 7 January 2025
Americas
Biotech walks away with another win as Fed Circ upholds PTAB decision | Labcorp’s attempt to overturn $373m verdict fails | Court finds Ravgen’s method for preserving DNA in blood samples not obvious. 7 January 2025
Careers
Two large teams leave Locke Lord following Troutman Pepper merger | Buchanan opens Chicago office with a large life sciences group | Shoosmiths adds team in London to expand brand-focused IP services. 7 January 2025
Careers
New partner brings technical background in computer science and more than a decade experience in patent litigation | Expertise in tech, engineering, chemical, and life sciences sectors. 7 January 2025
Americas
The Japanese pharma company files complaint against Lupin Pharmaceuticals | Suit alleges patent infringement over the company’s proposed generic version of a key ALS drug. 2 January 2025
Americas
In an incredibly competitive and complex landscape, intellectual property is a critical asset for pharmaceutical and biotech companies. 25 December 2024
Americas
As part of a lifecycle IP strategy for a therapeutic product, it can be important to protect inventions arising during the clinical development of the product. 25 December 2024
Americas
Dispute stems from Amneal’s efforts to market generic version of Teva’s inhaler for treating asthma | Precedential decision could restrict how brand-name pharmaceutical companies use the Orange Book to extend market exclusivity. 24 December 2024
Americas
In this session, Will James and Tim Harris will discuss their personal experiences litigating life sciences cases before the UPC. They will share their substantive and procedural insights, as well as strategic considerations and pitfalls to avoid. 24 December 2024
Americas
The Unified Patent Court (UPC) opened for business in June 2023. In this session, Ravi Srinivasan, partner at JA Kemp, explains how UPC litigation has been shaping up over the past year and shares practical tips based on experiences so far. 24 December 2024